JFL Life Sciences Board of Directors
Get the latest insights into the leadership at JFL Life Sciences. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Smiral Ashwinkumar Patel | Chairman & Managing Director |
| Mr. Manishkumar Jasvantlal Patel | Non Executive Director |
| Mrs. Tejal Smiral Patel | Executive Director & CFO |
| Ms. Sonu Lalitkumar Jain | Ind. Non-Executive Director |
| Ms. Bhavna Basantbhai Shah | Ind. Non-Executive Director |
JFL Life Sciences Share price
JFLLIFE
13.3
0.00 (0.00%)Last updated on 24 Sep, 2025 | 09:03 IST
BUYSELL
Today's High
00
Today's Low
00
52 Week Low
12.75
52 Week High
37.15
The current prices are delayed, login to your account for live prices
LoginJFL Life Sciences FAQs
The board at JFL Life Sciences consists of experienced professionals, including Mr. Smiral Ashwinkumar Patel , Mr. Manishkumar Jasvantlal Patel , and others, overseeing the company’s strategic and corporate governance.
Directors at JFL Life Sciences are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Smiral Ashwinkumar Patel is the current chairman at JFL Life Sciences.
Executive directors at JFL Life Sciences are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, JFL Life Sciences adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At JFL Life Sciences, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.